healthprotocol.wiki

Protocols Evidence Outcomes

medication-osteoporosis-zoledronic-acid-intravenous-every-three-week-dose-reduced-generic

Outcomes

01
oncology-skeletal-related-event-occurrence-detected-binary-measured
1 evidence row
- saad_2002_rct_zoledronic-acid-4mg-vs-placebo-sre-mcrpc
02
oncology-skeletal-related-event-time-to-first-event-months-measured
1 evidence row
- saad_2002_rct_zoledronic-acid-4mg-vs-placebo-sre-mcrpc

Evidence

1rows

On this page

Permalink

/protocols/medication-osteoporosis-zoledronic-acid-intravenous-every-three-week-dose-reduced-generic

healthprotocol.wiki

A community-driven, evidence-based health registry. Built for transparency.